Abstract
Anti-adrenergic therapy with β-adrenergic blocking agents has proved to be effective in the medical treatment of various dilated cardiomyopathies, including idiopathic, valvular and ischemic subtypes. This report will summarize the effects of β-blocker treatment on the dilated cardiomyopathy phenotype, as well as on clinical parameters.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
